1. Home
  2. IDYA vs ATS Comparison

IDYA vs ATS Comparison

Compare IDYA & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • ATS
  • Stock Information
  • Founded
  • IDYA 2015
  • ATS 1978
  • Country
  • IDYA United States
  • ATS Canada
  • Employees
  • IDYA N/A
  • ATS N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • ATS
  • Sector
  • IDYA Health Care
  • ATS
  • Exchange
  • IDYA Nasdaq
  • ATS Nasdaq
  • Market Cap
  • IDYA 2.3B
  • ATS 2.7B
  • IPO Year
  • IDYA 2019
  • ATS 2023
  • Fundamental
  • Price
  • IDYA $24.44
  • ATS $28.19
  • Analyst Decision
  • IDYA Buy
  • ATS
  • Analyst Count
  • IDYA 14
  • ATS 0
  • Target Price
  • IDYA $47.75
  • ATS N/A
  • AVG Volume (30 Days)
  • IDYA 1.2M
  • ATS 112.7K
  • Earning Date
  • IDYA 11-03-2025
  • ATS 08-07-2025
  • Dividend Yield
  • IDYA N/A
  • ATS N/A
  • EPS Growth
  • IDYA N/A
  • ATS N/A
  • EPS
  • IDYA N/A
  • ATS N/A
  • Revenue
  • IDYA $7,000,000.00
  • ATS $1,886,061,785.00
  • Revenue This Year
  • IDYA $62.30
  • ATS $17.75
  • Revenue Next Year
  • IDYA $285.58
  • ATS $6.27
  • P/E Ratio
  • IDYA N/A
  • ATS N/A
  • Revenue Growth
  • IDYA N/A
  • ATS N/A
  • 52 Week Low
  • IDYA $13.45
  • ATS $20.90
  • 52 Week High
  • IDYA $37.19
  • ATS $33.13
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 49.04
  • ATS 52.93
  • Support Level
  • IDYA $24.24
  • ATS $27.00
  • Resistance Level
  • IDYA $25.49
  • ATS $27.62
  • Average True Range (ATR)
  • IDYA 1.35
  • ATS 0.57
  • MACD
  • IDYA -0.15
  • ATS 0.21
  • Stochastic Oscillator
  • IDYA 27.13
  • ATS 72.51

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

Share on Social Networks: